INCY

NASDAQ · Biotechnology

Incyte Corp

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$124.53

-0.11 (-0.09%)

Analyst Consensus

Hold

Analysts

Very High

Coverage

Buy 18 51%

Hold 17 49%

Sell 0 0%

Price Target

Analyst Price Target +66.1% upside

Low Target $125.25

Average Target $206.81

High Target $260.19

Current Price $124.53

Current
$124.53

Target
$206.81

$125.25 $206.81 avg $260.19

Scenario Analysis

Bear Case

$125.25

0.6%

Low target

Base Case

$206.81

+66.1%

Avg target

Bull Case

$260.19

+108.9%

High target

Risk/Reward

188.4x

Highly favorable

Price in Context

52-Week High

$132.60

-6.1% from high

52-Week Low

$81.09

+53.6% from low

50-Day SMA

$101.74

+22.4% vs SMA

200-Day SMA

$86.15

+44.6% vs SMA

RSI (14)

51.1

Neutral

Target vs 52W High

$206.81

+56.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.1%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-22.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-42.7%